Acute Myeloid Leukemia (AML)-Derived Mesenchymal Stem Cells Induce Chemoresistance and Epithelial-Mesenchymal Transition-Like Program in AML Through IL-6/JAK2/STAT3 Signaling
Researchers found that AML-mesenchymal stem cellss induced a significant mesenchymal-like morphology in drug-resistant AML cells, but it was scarce in parental AML cells.